⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL939730 | 1.00 | — | — | |
| SCHEMBL1482554 | 1.00 | — | — | |
| SCHEMBL1482557 | 1.00 | — | — | |
| SCHEMBL4366326 | 1.00 | — | — | |
| SCHEMBL939729 | 1.00 | — | — | |
| SCHEMBL15276137 | 0.82 | — | — | |
| SCHEMBL15276139 | 0.82 | — | — | |
| SCHEMBL12391901 | 0.80 | — | — | |
| SCHEMBL12216536 | 0.80 | — | — | |
| SCHEMBL16214673 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101511841-B | Tetrahydrofuro [3,2-B ] pyrrol-3-ones as cathepsin K inhibitors | AMURA THERAPEUTICS LTD | 2013-08-07 | — | — | CN | disclosed |
| US-7799791-B2 | Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases | AMURA THERAPEUTICS LIMITED (GB) | 2010-09-21 | — | — | US | disclosed |
| CN-101511841-A | Tetrahydrofuro [3, 2-B ] pyrrol-3-ones as cathepsin K inhibitors | ARMURA THERAPEUTICS LTD (GB) | 2009-08-19 | — | — | CN | disclosed |
| CN-101506185-A | Tetrahydrofuro [3, 2-B] pyrrol-3-one intermediates | ARMURA THERAPEUTICS LTD (GB) | 2009-08-12 | — | — | CN | disclosed |
| EP-2081919-A1 | TETRAHYDROFURO [3, 2-B]PYRR0L-3-0NE INTERMEDIATES | Amura Therapeutics Limited (GB) | 2009-07-29 | — | — | EP | disclosed |
| US-20090186831-A1 | Tetrahydrofuro(3,2-B) pyrrol-3-one derivatives as inhibitors of cysteine proteinases | AMURA THERAPEUTICS LIMITED (GB) | 2009-07-23 | — | — | US | disclosed |
| EP-2046797-A1 | FURO [3,2-B]PYRROL-3-ONE DERIVATIVES AND THEIR USE AS CYSTEINYL PROTEINASE INHIBITORS | Amura Therapeutics Limited (GB) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008007127-A1 | FURO [3,2-B] PYRROL-3-ONE DERIVATIVES AND THEIR USE AS CYSTEINYL PROTEINASE INHIBITORS | AMURA THERAPEUTICS LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008007132-A1 | TETRAHYDROFURO [3, 2-B] PYRR0L-3-0NE INTERMEDIATES | AMURA THERAPEUTICS LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008007132-A1 | TETRAHYDROFURO [3, 2-B] PYRR0L-3-0NE INTERMEDIATES | AMURA THERAPEUTICS LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |